Home » Archive by Category


Intrigue and Outdated Rules Complicate Big Biotech Patent Fight

December 16, 2014 – 4:30 am | Edit Post

How’s this for strange? What’s likely the most important biotech patent battle of the decade is now being fought under outmoded rules that the U.S. Congress, in a rare spasm of common…
[[Click headline to continue reading.]]

West Coast Biotech Roundup: Versant, BayBio/CHI Merger, von Emster

December 11, 2014 – 11:48 am | Edit Post

A programming note: The American Society of Hematology’s annual meeting, which took place Friday through Tuesday in San Francisco, took up much of the week’s biopharma news. We’ve decided…
[[Click headline to continue reading.]]

Members Push Merger of 2 California Life Sciences Industry Groups

December 8, 2014 – 10:01 pm | Edit Post

The move to combine two nonprofits that are dedicated to advancing California’s life sciences interests was set in motion 11 months ago, when CEO David Gollaher resigned from the San Diego-based…
[[Click headline to continue reading.]]

Pioneer’s Lament: Lack of Checkpoint Immunotherapy For Blood Cancer

December 8, 2014 – 6:38 pm | Edit Post

It might be hard to tell these days, but cancer immunotherapy can be disappointing, too. In a lunchtime review Monday at the American Society of Hematology annual meeting in San Francisco, Ronald…

[[Click headline to continue reading.]]

Immunotherapy Confidence (And Audience) Abundant At ASH T-Cell Talk

December 8, 2014 – 11:16 am | Edit Post

With cancer immunotherapy tallying impressive patient results and new drug approvals, people in the field are confident about expanding its scope. That confidence was abundant in back-to-back…

[[Click headline to continue reading.]]

Amid String of Exits for VenBio, a Founding Partner Leaves, Too

December 5, 2014 – 1:59 pm | Edit Post

With three acquisitions of its portfolio companies, San Francisco biotech investment firm venBio has had a few good exits recently. Now one of its partners is exiting, too. Kurt Von Emster, one of…

[[Click headline to continue reading.]]

“Connect 3.0” Names San Diego’s Most Innovative Products of 2014

December 5, 2014 – 1:17 am | Edit Post

A security startup that detects anomalous cyber behavior and a life sciences company that makes 3D liver tissue for use in drug toxicity testing were among eight San Diego companies that won engraved…

[[Click headline to continue reading.]]

Roche Enters Noninvasive Prenatal Test Market With Ariosa Purchase

December 2, 2014 – 12:13 pm | Edit Post

Eyeing the biotech IPO boom earlier this year, Ariosa Diagnostics planned to go public as it battled larger competitors in the prenatal testing field. But the San Jose, CA-based company backed off in…

[[Click headline to continue reading.]]

More Biotechs Belly-Up These Days but Dendreon Still “One of a Kind”

December 2, 2014 – 4:31 am | Edit Post

Biotech companies rarely go bankrupt. Sitting where I sit, that bit of conventional wisdom comes around every so often, although it doesn’t generate quite the same buzz as Halley’s Comet…
[[Click headline to continue reading.]]

Prescription Drug Pricing: The Fine Line Between Value and Greed

December 2, 2014 – 1:00 am | Edit Post

Value. It’s one of the most frequently used buzzwords on both Wall Street and in healthcare. Virtually every press release from a publicly traded company assures us that its latest…
[[Click headline to continue reading.]]